{"id":{"repo_id":"montana-tech","oai_identifier":"oai:scholarworks.umt.edu:etd-1374"},"canonical_url":"https://search.dev.ndltd.org/etd/montana-tech/oai:scholarworks.umt.edu:etd-1374","repository":{"repo_id":"montana-tech","name":"Montana Technology","base_url":"https://scholarworks.umt.edu/do/oai/"},"display":{"title":"Effects of a yeast β-glucan supplement on symptoms of upper respiratory tract infection in free-living college-aged males","abstract":"The focus of previous research has demonstrated that both oat and yeast ß-glucan benefits immunosuppressed populations. However, previous research has not, to our knowledge, investigated the effects of a yeast ß-glucan on the ummune functioning of healthy, free-living human populations. PURPOSE: The goal of this research was to evaluate the effects of a yeast ß-glucan on symptoms of upper respiratory tract infection in healthy, free-living, college-aged males. METHODOLOGY: The WURSS-44, a reliable, validated survey used for determining symptoms of upper respiratory tract infection was filled out online daily by 79 male subjects between the ages of 18 and 40. Subjects were given a bottle of 250 mg capsules of either yeast ß-glucan or placebo to take daily. RESULTS: Yeast ß-glucan demonstrated no statistically significant effect on the experimental subject population for any of the variables associated with symptoms of upper respiratory tract infection. CONCLUSION: Yeast ß-glucan does not significantly improve immune functioning in healthy, free-living college aged males.","abstract_html":"The focus of previous research has demonstrated that both oat and yeast ß-glucan benefits immunosuppressed populations. However, previous research has not, to our knowledge, investigated the effects of a yeast ß-glucan on the ummune functioning of healthy, free-living human populations. PURPOSE: The goal of this research was to evaluate the effects of a yeast ß-glucan on symptoms of upper respiratory tract infection in healthy, free-living, college-aged males. METHODOLOGY: The WURSS-44, a reliable, validated survey used for determining symptoms of upper respiratory tract infection was filled out online daily by 79 male subjects between the ages of 18 and 40. Subjects were given a bottle of 250 mg capsules of either yeast ß-glucan or placebo to take daily. RESULTS: Yeast ß-glucan demonstrated no statistically significant effect on the experimental subject population for any of the variables associated with symptoms of upper respiratory tract infection. CONCLUSION: Yeast ß-glucan does not significantly improve immune functioning in healthy, free-living college aged males.","abstract_has_math":false,"creators":["Gorham, Casey E"],"institution":"University of Montana","degree_name":"Master of Science (MS)","degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2009,"date_issued":"2009-01-01T08:00:00Z","date_published":"2009-01-01T08:00:00Z","updated_at":"2026-07-24T03:12:58Z","subjects":["immune","resistance","ß-glucan","susceptibility"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://scholarworks.umt.edu/etd/355","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Gorham, Casey E"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:publisher","label":"Institution","values":["University of Montana"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["immune","resistance","ß-glucan","susceptibility"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://scholarworks.umt.edu/etd/355"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The focus of previous research has demonstrated that both oat and yeast ß-glucan benefits immunosuppressed populations. However, previous research has not, to our knowledge, investigated the effects of a yeast ß-glucan on the ummune functioning of healthy, free-living human populations. PURPOSE: The goal of this research was to evaluate the effects of a yeast ß-glucan on symptoms of upper respiratory tract infection in healthy, free-living, college-aged males. METHODOLOGY: The WURSS-44, a reliable, validated survey used for determining symptoms of upper respiratory tract infection was filled out online daily by 79 male subjects between the ages of 18 and 40. Subjects were given a bottle of 250 mg capsules of either yeast ß-glucan or placebo to take daily. RESULTS: Yeast ß-glucan demonstrated no statistically significant effect on the experimental subject population for any of the variables associated with symptoms of upper respiratory tract infection. CONCLUSION: Yeast ß-glucan does not significantly improve immune functioning in healthy, free-living college aged males."]},{"key":"dc:title","label":"Title","values":["Effects of a yeast β-glucan supplement on symptoms of upper respiratory tract infection in free-living college-aged males"]}]}],"canonical_facts":{"dc:creator":["Gorham, Casey E"],"dc:description.abstract":["The focus of previous research has demonstrated that both oat and yeast ß-glucan benefits immunosuppressed populations. However, previous research has not, to our knowledge, investigated the effects of a yeast ß-glucan on the ummune functioning of healthy, free-living human populations. PURPOSE: The goal of this research was to evaluate the effects of a yeast ß-glucan on symptoms of upper respiratory tract infection in healthy, free-living, college-aged males. METHODOLOGY: The WURSS-44, a reliable, validated survey used for determining symptoms of upper respiratory tract infection was filled out online daily by 79 male subjects between the ages of 18 and 40. Subjects were given a bottle of 250 mg capsules of either yeast ß-glucan or placebo to take daily. RESULTS: Yeast ß-glucan demonstrated no statistically significant effect on the experimental subject population for any of the variables associated with symptoms of upper respiratory tract infection. CONCLUSION: Yeast ß-glucan does not significantly improve immune functioning in healthy, free-living college aged males."],"dc:identifier":["https://scholarworks.umt.edu/etd/355"],"dc:publisher":["University of Montana"],"dc:subject":["immune","resistance","ß-glucan","susceptibility"],"dc:title":["Effects of a yeast β-glucan supplement on symptoms of upper respiratory tract infection in free-living college-aged males"],"dc:type":["Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-07-24T03:12:58Z"}